DRW Securities’s Biodesix BDSX Stock Holding History

DRW Securities’s Portfolio BDSX Stock Details BDSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,372	Closed	-$105K	–	1300
2025 Q4	$105K	Buy	+15,372	New	+$113K	﹤0.01%	1063

Other funds holding BDSX

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

DRW Securities's BDSX Position: Q1 2026 in Review

DRW Securities sold out of Biodesix (BDSX) in Q1 2026, closing a stake of 15,372 shares — an estimated $105K sold.

DRW Securities first reported a position in BDSX in Q4 2025 and held it in 1 quarter. The position peaked at $105K in Q4 2025. 40 funds tracked by Wall St. Rank hold BDSX as of Q1 2026.

DRW Securities reported no remaining Biodesix position as of Q1 2026 after selling out during the quarter.
DRW Securities sold 15,372 Biodesix shares in Q1 2026, an estimated $105K.
DRW Securities first reported a position in Biodesix in Q4 2025 and held it in 1 quarter.
DRW Securities's Biodesix position peaked at $105K in Q4 2025.
40 funds tracked by Wall St. Rank held Biodesix as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.